What are the benefits of intravenous administration of human immunoglobulin (pH4) in elderly patients?

Generally, "Jing Bing" refers to intravenous human immunoglobulin (pH4), which can provide immune-regulating benefits for elderly patients. Intravenous human immunoglobulin (pH4) is clinically used in the treatment of various immune deficiency-related diseases, organ transplantation, severe infections, and more. The details are as follows:

Intravenous human immunoglobulin (pH4) is a medication that enhances the body's immunity. Its main component consists of broad-spectrum IgG antibodies, providing both immunoglobulin replacement and immunomodulatory effects. It can recognize and bind to antigens, activate complement systems, promote macrophage responses, and neutralize viruses and toxins. Clinically, it is commonly used to treat congenital gamma globulin deficiency. Intravenous human immunoglobulin (pH4) appears as a transparent, odorless solution. After injection, it exerts health-protective effects in elderly individuals by enhancing resistance, regulating bodily functions, and improving overall physical condition. It can be administered via injection and also helps replenish the body's globulin levels, providing antibacterial effects and contributing to systemic regulation.

During administration of intravenous human immunoglobulin (pH4), a very small number of patients may experience transient adverse reactions such as headache, palpitations, or nausea, usually related to too rapid infusion rates or individual differences. Most of these reactions are mild and typically occur within the first hour of infusion. Therefore, it is recommended to closely monitor the patient's general condition and vital signs during the first hour of infusion.

If needed, this medication should only be used under the guidance of a qualified physician. Self-administration without medical supervision must be avoided to prevent potential harm to health.